Recombinant anti-SMAD7 intrabody linked to (D-Arg)9 works within cells and directs against SMAD7, expressed in CHO cells. The intrabody relates to inhibito Smad7 expression or function for the preparation of a pharmaceutical composition for the prevention, amelioration or treatment of a disease of the central nervous system and/or diseases related and/or caused by said disease of the central nervous system.
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Download resources about recombinant antibody development and antibody engineering to boost your research.
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
MOB-4083z | Mouse Anti-SMAD7 Recombinant Antibody (clone 21B4) | WB, IP, IF, ELISA | Mouse IgG1, κ |
MOB-1117CT | Recombinant Mouse anti-Human SMAD7 Monoclonal antibody (EML551) | IHC-P, WB | |
VS3-XY1437 | Mouse Anti-SMAD7 Recombinant Antibody (clone 3E3) | WB, IHC |
There are currently no Customer reviews or questions for IAB-B025(A). Click the button above to contact us or submit your feedback about this product.
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.